Delivery Order SPE2DB25D3012-SPE2DB25FWVUS
Award Date
2/28/25
Potential Completion Date
3/3/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,310.40 firm fixed-price delivery order contract is for the supply of the pharmaceutical product Budesonide-Formoterol 160-4.5 10.2GM. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,875.41, is for the delivery of budesonide-formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with a completion date of November 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Budesonide-Formoterol 80-4.5 10.2 GM, a pharmaceutical product, with a ceiling value of $3,540.00 and an ultimate completion date of November 21, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, and has a total ceiling value of $16,773.40. The contract is a firm fixed-price delivery order with a performance period ending on February 5, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,313.40, is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of January 6, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of budesonide-formoterol 160-4.5 10.2GM medical supplies, with a total ceiling value of $3,715.07. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a...
This federal contract award, valued at $1,372.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a completion date of February 20, 2025. The contract is a Delivery Order under a Firm Fixed Price structure, and there was no set-aside designation used. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2 gram medication, with a ceiling value of $1,206.49. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 4, 2024. This award is not associated with a set-aside designation....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,701.39, is a Delivery Order for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a prescription medication. The contract has an ultimate completion date of December 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,397.76, is for the delivery of budesonide-formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 27, 2025. The award is not designated with a set-aside requirement, indicating open...